Back

Comparing pulsed field electroporation and radiofrequency ablation for the treatment of atypical atrial flutter

14 April 2026 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Atrial flutter ablation Treatment EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Samuel Azevedo

Hospital Santa Cruz, Lisbon (Portugal)

7 More presentations in this session

Presentation thumbnail
From anatomy to ablation: intracardiac echocardiography-guided cavotricuspid isthmus morphology and procedural outcomes in typical atrial flutter
Doctor M. Gabarin (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Efficacy, safety and very long term recurrences of cavo-tricuspid isthmus-dependent atrial flutter ablation: a large multicenter observational study.
Doctor M. Manfrin (Bolzano, IT)
Abstract Slides Video
Presentation thumbnail
Predictors of recurrence after ablation of atypical atrial flutter: insights from a real-world cohort
Doctor S. Azevedo (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Predictors of outcome after catheter ablation of atypical atrial flutter
Doctor K. Janosi (Pecs, HU)
Abstract Slides Video
Presentation thumbnail
Atypical atrial flutter after AF ablation vs De Novo atypical flutter: are they the same?
Doctor S. Azevedo (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial flutter ablation

The Event

Event poster

EHRA 2026

14 April 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Catheter ablation of atypical left atrial flutter - Comparison of outcomes between pulsed field ablation and radiofrequency ablation
thumbnail
Congress Presentation
Predictors of recurrence after ablation of atypical atrial flutter: insights from a real-world cohort
thumbnail
Congress Presentation
Treatment of mapped left atrial macroreentrant flutter with electroporation: results and comparison with radiofrequency

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources